COVID-19 WARNING! Females Who Are Pregnant Or Taking Estrogen With Birth Control or Hormone Replacement Therapy At Risk Of Blood Clots From COVID-19
Source: COVID-19 Warning Jul 30, 2020 5 years, 11 months, 2 weeks, 1 day, 13 hours, 17 minutes ago
COVID-19 Warning: According to researchers from Maine Medical Center- Portland and Tufts University Scholl of Medicine-Boston, COVID-19 may increase the risk of blood clots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy.
.jpg)
It has already been observed that one of the many complications of COVID-19 is the formation of blood clots in previously healthy people.
The hormone estrogen increases the chance of blood clots during pregnancy and in women taking birth control pills or hormone replacement therapy.
According to the research, if infected with COVID-19, these women's risk of blood clotting could be even higher, and they may need to undergo anticoagulation therapy or to discontinue their estrogen medicines.
The research findings were published in the Endocrine Society's journal, Endocrinology.
https://academic.oup.com/endo/article/doi/10.1210/endocr/bqaa121/5874354?searchresult=1
The study's corresponding author, Dr Daniel I. Spratt, M.D., of Maine Medical Center in Portland, Maine, and Tufts University School of Medicine in Boston, Massa chusetts told Thailand Medical News, "During this pandemic, we need additional research to determine if women who become infected with the coronavirus during pregnancy should receive anticoagulation therapy or if women taking birth control pills or hormone replacement therapy should discontinue them. Research that helps us understand how the coronavirus causes blood clots may also provide us with new knowledge regarding how blood clots form in other settings and how to prevent them."
To date, researching and understanding the cause of blood clotting in COVID-19, including the intersecting effects of estrogen therapy or pregnancy, has several hurdles and will require innovative animal and tissue models.
Conversations between clinicians and basic researchers and between endocrinologists and hematologists are necessary to explore potential interactions between SARS-CoV-2, the coronavirus that causes COVID-19 and pregnancy or estrogen therapy that could guide clinical management.
For more
COVID-19 Warnings, stay tuned to Thailand Medical News.
